Commercial Service for Custom Antibody Production
Liselo is able to manufacture polyclonal IgY antibodies against a very broad range of target antigens on demand. The Liselo QBP is a platform for the bespoke production of chimeric “otherised” therapeutic antibody products at affordable prices and in large quantities, with very short turn-around times. Liselo is gearing this platform to be able to respond rapidly to potential outbreaks of emerging and re-emerging zoonotic diseases.
Customer supplied antigens or sequence accession numbers, can be used to generate custom polycloncal antibodies within 6-12 weeks, in quantities ranging from 100mg to 10g. Lead times for humanised or otherised MAb’s can be as little as 14 weeks, depending on the project.